LADIGAGA - Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510741-33-00

Acronym

P170919

Enrollment

Registered

2024-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular degeneration

Brief summary

Rate of Change in Area of Geographic Atrophy (GA), based on masked, digital grading as measured on Fundus Auto-fluorescence ((FAF) Imaging Using a Confocal Scanning Ophthalmoscope by an External Reading Center at 12, Months compared to value at Baseline Day 1

Interventions

DRUGDIMETHYL FUMARATE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Rate of Change in Area of Geographic Atrophy (GA), based on masked, digital grading as measured on Fundus Auto-fluorescence ((FAF) Imaging Using a Confocal Scanning Ophthalmoscope by an External Reading Center at 12, Months compared to value at Baseline Day 1	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026